Takeda invests $760M+ into new plasma-derived therapy manufacturing site in Japan

Takeda invests $760M+ into new plasma-derived therapy manufacturing site in Japan

Source: 
Endpoints
snippet: 

The Japanese pharma giant Takeda will be making a significant investment close to home as it expands its capabilities in plasma therapy manufacturing.